Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11246909 Neuregulin based methods for treating heart failure

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

February 15, 2022

Patent Application Number

15601856

Date Filed

May 22, 2017

Patent Citations

US Patent 10227418 Neukinase, a downstream protein of neuregulin

US Patent 10561709 Methods and compositions of neuregulins for preventing, treating or delaying preserved ejection fraction cardiac failure

US Patent 10441633 Uses of neuregulin in preventing, treating or delaying ventricular arrhythmia, and composition thereof

US Patent 10702585 Formula of neuregulin preparation

US Patent 10098834 Extended release of neuregulin for treating heart failure

US Patent 10112983 Neuregulin variants and methods of screening and using thereof

Patent Primary Examiner

Christine J. Saoud

Patent abstract

The present invention features methods of treating patients with chronic heart failure by administering a neuregulin polypeptide within a dosage range which is both effective and safe.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11246909 Neuregulin based methods for treating heart failure

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool